PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study.

MLA

Grantzau, Trine, et al. “PD-L1 Expression and FGFR-Mutations among Danish Patients Diagnosed with Metastatic Urothelial Carcinoma: A Retrospective and Descriptive Study.” APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica, vol. 130, no. 8, Aug. 2022, pp. 498–506. EBSCOhost, https://doi.org/10.1111/apm.13249.

APA

Grantzau, T., Toft, B. G., Melchior, L. C., Elversang, J., Stormoen, D. R., Omland, L. H., & Pappot, H. (2022). PD-L1 expression and FGFR-mutations among Danish patients diagnosed with metastatic urothelial carcinoma: A retrospective and descriptive study. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 130(8), 498–506. https://doi.org/10.1111/apm.13249

Chicago

Grantzau, Trine, Birgitte Grønkaer Toft, Linea Cecilie Melchior, Johanna Elversang, Dag Rune Stormoen, Lise Høj Omland, and Helle Pappot. 2022. “PD-L1 Expression and FGFR-Mutations among Danish Patients Diagnosed with Metastatic Urothelial Carcinoma: A Retrospective and Descriptive Study.” APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 130 (8): 498–506. doi:10.1111/apm.13249.